Mark Lackner

Companies

• Zentalis Pharmaceuticals, Inc.Chief Scientific Officer Jan 3, 2024 to Feb 5, 2025¹
• Ideaya Biosciences (United States)SVP, Head of Biology May 22, 2019 to Feb 26, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ZPZentalis Pharmaceuticals, Inc. ZNTL512,856 shares³$1.2M at $2.29Feb 3, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 3, 2025Sold 14,368 shares at $1.71 of Zentalis Pharmaceuticals, Inc.³
• Feb 3, 2025Granted 335,907 shares of Zentalis Pharmaceuticals, Inc.³
• Jan 2, 2025Sold 4,411 shares at $3.12 of Zentalis Pharmaceuticals, Inc.⁴
• Feb 2, 2024Sold 1,585 shares at $11.54 of Zentalis Pharmaceuticals, Inc.⁵
• Feb 1, 2024Granted 141,000 shares of Zentalis Pharmaceuticals, Inc.⁵
• Jan 2, 2024Granted 40,000 shares of Zentalis Pharmaceuticals, Inc.⁶